Your browser doesn't support javascript.
loading
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.
Kusumoto, Shigeru; Tanaka, Yasuhito; Suzuki, Ritsuro; Watanabe, Takashi; Nakata, Masanobu; Sakai, Rika; Fukushima, Noriyasu; Fukushima, Takuya; Moriuchi, Yukiyoshi; Itoh, Kuniaki; Nosaka, Kisato; Choi, Ilseung; Sawa, Masashi; Okamoto, Rumiko; Tsujimura, Hideki; Uchida, Toshiki; Suzuki, Sachiko; Okamoto, Masataka; Takahashi, Tsutomu; Sugiura, Isamu; Onishi, Yasushi; Kohri, Mika; Yoshida, Shinichiro; Kojima, Minoru; Takahashi, Hiroyuki; Tomita, Akihiro; Atsuta, Yoshiko; Maruyama, Dai; Tanaka, Eiji; Suzuki, Takayo; Kinoshita, Tomohiro; Ogura, Michinori; Ueda, Ryuzo; Mizokami, Masashi.
Afiliação
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Tanaka Y; Department of Virology and Liver unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Suzuki R; Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan.
  • Watanabe T; Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Mie, Japan.
  • Nakata M; Department of Internal Medicine, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Sakai R; Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Fukushima N; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
  • Fukushima T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Moriuchi Y; Department of Hematology, Sasebo City General Hospital, Sasebo, Japan.
  • Itoh K; Divisions of Oncology and Hematology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Nosaka K; Department of Hematology and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto, Japan.
  • Choi I; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
  • Okamoto R; Department of Oncology, Chibanishi general Hospital, Chiba, Japan.
  • Tsujimura H; Division of Hematology-Oncology, Chiba Cancer Center, Chiba, Japan.
  • Uchida T; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Suzuki S; Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
  • Okamoto M; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Takahashi T; Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan.
  • Sugiura I; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Onishi Y; Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Kohri M; Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan.
  • Yoshida S; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Ohmura, Japan.
  • Kojima M; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Takahashi H; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan.
  • Tomita A; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Atsuta Y; Department of Hematopoietic Stem Cell Transplantation Data Management and Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Tanaka E; Department for the Promotion of Regional Medicine, Shinshu University School of Medicine, Matsumoto, Japan.
  • Suzuki T; Department of Hematology, Kusatsu General Hospital, Kusatsu, Japan.
  • Kinoshita T; Japanese Red Cross Aichi Blood Center, Aichi, Japan.
  • Ogura M; Department of Hematology and Oncology, Kasugai Municipal Hospital, Kasugai, Japan.
  • Ueda R; Department of Tumor Immunology, Aichi Medical University School of Medicine, Aichi, Japan.
  • Mizokami M; Genome Medical Science Project, National Center for Global Health and Medicine, Ichikawa, Japan. Electronic address: mmizokami@hospk.ncgm.go.jp.
J Hepatol ; 73(2): 285-293, 2020 08.
Article em En | MEDLINE | ID: mdl-32194183
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Monitoramento de Medicamentos / Hepatite B Crônica / Rituximab / Reinfecção / Antígenos de Superfície da Hepatite B / Linfoma Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Hepatite B / Monitoramento de Medicamentos / Hepatite B Crônica / Rituximab / Reinfecção / Antígenos de Superfície da Hepatite B / Linfoma Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article